Emergent BioSolutions EBS
NYSE EBS
$6.12 -0.24 (-3.70%)
As of: Oct 20, 2026 · 9:53 AM EDT

Emergent BioSolutions (EBS) Ending Cash Balance (2013 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Ending Cash Balance (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,159.35 Bn 1,127.94 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 625.57 Bn 544.10 Bn 17.26 Bn 20.42 Bn
3 AbbVie 510.56 Bn 483.67 Bn 12.70 Bn 6.57 Bn
4 Merck 366.80 Bn 321.17 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 296.71 Bn 260.70 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 260.68 Bn 234.36 Bn 12.86 Bn 4.88 Bn
7 Amgen 235.19 Bn 190.59 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.90 Bn 169.09 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 1.03 Bn
10 Emergent BioSolutions 315.28 Mn -435.62 Mn 137.20 Mn 140.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.90 Mn
Mar 31, 2026 161.50 Mn
Dec 31, 2025 209.10 Mn
Sep 30, 2025 249.20 Mn
Jun 30, 2025 271.00 Mn
Mar 31, 2025 152.80 Mn
Dec 31, 2024 105.60 Mn
Sep 30, 2024 156.40 Mn
Jun 30, 2024 71.00 Mn
Mar 31, 2024 79.00 Mn
Dec 31, 2023 111.70 Mn
Sep 30, 2023 87.80 Mn
Jun 30, 2023 88.60 Mn
Mar 31, 2023 430.20 Mn
Dec 31, 2022 642.60 Mn
Sep 30, 2022 241.00 Mn
Jun 30, 2022 358.30 Mn
Mar 31, 2022 436.00 Mn
Dec 31, 2021 576.30 Mn
Sep 30, 2021 404.00 Mn
API Access

Emergent BioSolutions Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=EBS&period=max&api_key=YOUR_API_KEY